Hyponatraemia induced by low-dose intravenous pulse cyclophosphamide

38Citations
Citations of this article
21Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background. Cyclophosphamide is an alkylating agent and was traditionally known to potentiate the renal action of vasopressin. Although low-dose intravenous pulse cyclophosphamide therapy is being used extensively in the treatment of malignant and rheumatological diseases, there have been only a few case reports of cyclophosphamide-induced hyponatraemia.Methods. Clinical data were retrospectively analysed from 84 patients (42 lupus nephritis; 42 non-Hodgkin's lymphoma; a total of 112 treatment episodes) admitted for intravenous pulse cyclophosphamide (500-750 mg/m2) therapy. In all patients, half-isotonic saline was used for prophylactic hydration. Cyclophosphamide-induced hyponatraemia was defined as serum sodium concentration <135 mEq/L at 24 hours after the therapy in patients whose basal serum sodium concentrations were normal.Results. After the low-dose intravenous pulse cyclophosphamide, serum sodium concentration significantly decreased from 139.9 ± 3.5 to 137.9 ± 5.1 mEq/L (P < 0.001). Cyclophosphamide- induced hyponatraemia occurred in 15 treatment episodes (13.4%) from 12 patients (14.3%). Patients with hyponatraemia were significantly older than those without hyponatraemia (57.3 ± 14.7 vs. 40.0 ± 17.0 years, P < 0.01). Hyponatraemia was associated with male sex on univariate analysis (P < 0.05), but not on multivariate analysis. No factors were found to independently predict the occurrence of cyclophosphamide-induced hyponatraemia when multivariate analysis was performed including parameters age, sex, underlying disease, presence or absence of comorbidities associated with hyponatraemia, presence or absence of concurrent medications associated with hyponatraemia and dose of cyclophosphamide.Conclusions. Hyponatraemia occurring after low-dose intravenous pulse cyclophosphamide is not rare, especially when hypotonic solutions are adopted for hydration protocol. Thus, the use of hypotonic fluids should be avoided when using cyclophosphamide. Instead, isotonic solutions should be used if a forced diuresis is required. © The Author 2009. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved.

References Powered by Scopus

Chemotherapy-induced nausea and vomiting

689Citations
N/AReaders
Get full text

Vincristine neurotoxicity

213Citations
N/AReaders
Get full text

High‐dose cyclophosphamide therapy for malignant disease. Toxicity, tumor response, and the effects of stored autologous marrow

189Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Electrolyte disorders associated with the use of anticancer drugs

58Citations
N/AReaders
Get full text

Electrolyte Disorders Induced by Antineoplastic Drugs

52Citations
N/AReaders
Get full text

Using cyclophosphamide in inflammatory rheumatic diseases

51Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Lee, Y. C., Park, J. S., Lee, C. H., Bae, S. C., Kim, I. S., Kang, C. M., & Kim, G. H. (2010). Hyponatraemia induced by low-dose intravenous pulse cyclophosphamide. Nephrology Dialysis Transplantation, 25(5), 1520–1524. https://doi.org/10.1093/ndt/gfp657

Readers over time

‘11‘12‘14‘15‘16‘17‘18‘19‘20‘21‘22‘2401234

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 7

47%

Professor / Associate Prof. 4

27%

Researcher 3

20%

Lecturer / Post doc 1

7%

Readers' Discipline

Tooltip

Medicine and Dentistry 12

80%

Pharmacology, Toxicology and Pharmaceut... 1

7%

Social Sciences 1

7%

Psychology 1

7%

Save time finding and organizing research with Mendeley

Sign up for free
0